Cubist Systematic Strategies, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,783,919
-60.5%
242,713
-12.9%
0.02%
-55.3%
Q2 2023$7,054,074
+10.9%
278,707
+41.1%
0.05%
+20.5%
Q1 2023$6,361,024
+21.8%
197,486
-30.2%
0.04%
+30.0%
Q4 2022$5,220,986
+81.3%
282,827
+165.2%
0.03%
+87.5%
Q3 2022$2,879,000
-15.0%
106,628
-56.5%
0.02%
-23.8%
Q2 2022$3,389,000
+640.0%
245,212
+943.2%
0.02%
+425.0%
Q1 2022$458,000
-49.4%
23,505
-57.7%
0.00%
-55.6%
Q4 2021$906,000
+63.5%
55,506
+179.0%
0.01%
+28.6%
Q3 2021$554,000
-46.1%
19,898
-42.7%
0.01%
-41.7%
Q2 2021$1,028,000
+378.1%
34,698
+351.2%
0.01%
+300.0%
Q1 2021$215,000
-74.9%
7,690
-77.4%
0.00%
-76.9%
Q3 2020$856,000
-46.7%
34,052
-68.6%
0.01%
-69.8%
Q1 2020$1,605,000
+114.6%
108,435
+135.3%
0.04%
+207.1%
Q4 2019$748,000
+60.2%
46,085
+28.1%
0.01%
+55.6%
Q2 2019$467,000
-16.6%
35,982
+1.3%
0.01%
-50.0%
Q1 2019$560,000
+132.4%
35,511
+303.8%
0.02%
+50.0%
Q2 2018$241,000
+27.5%
8,795
+43.2%
0.01%
+9.1%
Q1 2018$189,0006,1410.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders